Source: Stem Cells Translational Medicine. Unidade: ICB
Subjects: APOPTOSE, ENDOTÉLIO, INSUFICIÊNCIA RENAL AGUDA, FISIOPATOLOGIA, IMUNOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CÓNDOR, Jose M. et al. Treatment with human wharton's Jelly-derived Mesenchymal stem cells attenuates sepsis-induced kidney injury, liver Injury, and endothelial dysfunction. Stem Cells Translational Medicine, v. 5, n. 8, p. 1048-1057, 2016Tradução . . Disponível em: https://doi.org/10.5966/sctm.2015-0138. Acesso em: 01 set. 2024.APA
Cóndor, J. M., Rodrigues, C. E., Moreira, R. de S., Canale, D., Volpini, R. A., Shimizu, M. H. M., et al. (2016). Treatment with human wharton's Jelly-derived Mesenchymal stem cells attenuates sepsis-induced kidney injury, liver Injury, and endothelial dysfunction. Stem Cells Translational Medicine, 5( 8), 1048-1057. doi:10.5966/sctm.2015-0138NLM
Cóndor JM, Rodrigues CE, Moreira R de S, Canale D, Volpini RA, Shimizu MHM, Câmara NOS, Noronha I de L, Andrade L. Treatment with human wharton's Jelly-derived Mesenchymal stem cells attenuates sepsis-induced kidney injury, liver Injury, and endothelial dysfunction [Internet]. Stem Cells Translational Medicine. 2016 ; 5( 8): 1048-1057.[citado 2024 set. 01 ] Available from: https://doi.org/10.5966/sctm.2015-0138Vancouver
Cóndor JM, Rodrigues CE, Moreira R de S, Canale D, Volpini RA, Shimizu MHM, Câmara NOS, Noronha I de L, Andrade L. Treatment with human wharton's Jelly-derived Mesenchymal stem cells attenuates sepsis-induced kidney injury, liver Injury, and endothelial dysfunction [Internet]. Stem Cells Translational Medicine. 2016 ; 5( 8): 1048-1057.[citado 2024 set. 01 ] Available from: https://doi.org/10.5966/sctm.2015-0138